Lupin Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 91.32 | 91.14 | 91.00 | 90.90 | 90.74 |
Reserves | 24,186.92 | 20,511.87 | 18,320.86 | 18,059.29 | 18,474.78 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.08 | 0.00 | 0.00 | 0.05 |
Total Shareholders Funds | 24,278.24 | 20,603.09 | 18,411.86 | 18,150.19 | 18,565.57 |
Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 50.79 |
Unsecured Loans | 250.13 | 104.93 | 748.51 | 950.85 | 434.67 |
Total Debt | 250.13 | 104.93 | 748.51 | 950.85 | 485.46 |
Other Liabilities | 508.74 | 426.89 | 393.84 | 338.24 | 357.66 |
Total Liabilities | 25,037.11 | 21,134.91 | 19,554.21 | 19,439.28 | 19,408.69 |
APPLICATION OF FUNDS : | |||||
Gross Block | 8,672.99 | 7,605.39 | 7,408.43 | 6,705.14 | 6,230.28 |
Less: Accumulated Depreciation | 3,727.13 | 3,492.22 | 3,386.50 | 3,014.96 | 2,591.45 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 4,945.86 | 4,113.17 | 4,021.93 | 3,690.18 | 3,638.83 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 278.37 | 445.83 | 926.59 | 947.44 | 950.86 |
Investments | 11,955.03 | 11,580.67 | 9,974.33 | 9,511.09 | 9,562.58 |
Current Assets, Loans & Advances | |||||
Inventories | 3,227.22 | 2,969.31 | 3,019.47 | 3,177.14 | 2,708.19 |
Sundry Debtors | 5,664.35 | 3,842.15 | 2,674.42 | 2,722.01 | 3,190.54 |
Cash and Bank Balance | 458.58 | 138.64 | 100.97 | 64.56 | 284.01 |
Loans and Advances | 1,540.84 | 1,528.92 | 1,336.29 | 1,651.71 | 1,113.64 |
Total Current Assets | 10,890.99 | 8,479.02 | 7,131.15 | 7,615.42 | 7,296.38 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 2,715.64 | 2,783.94 | 2,132.40 | 1,887.09 | 1,693.38 |
Provisions | 523.95 | 848.00 | 812.04 | 800.25 | 539.17 |
Total CL & Provisions | 3,239.59 | 3,631.94 | 2,944.44 | 2,687.34 | 2,232.55 |
Net Current Assets | 7,651.40 | 4,847.08 | 4,186.71 | 4,928.08 | 5,063.83 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 279.05 | 224.38 | 187.25 | 0.00 | 0.00 |
Deferred Tax Liability | 434.34 | 380.39 | 372.27 | 186.75 | 217.32 |
Net Deferred Tax | -155.29 | -156.01 | -185.02 | -186.75 | -217.32 |
Other Assets | 361.74 | 304.17 | 629.67 | 549.24 | 409.91 |
Total Assets | 25,037.11 | 21,134.91 | 19,554.21 | 19,439.28 | 19,408.69 |
Contingent Liabilities | 3,637.35 | 3,538.70 | 4,312.64 | 3,472.56 | 4,875.59 |